Genoil Inc.

As of December 31, 2025, Genoil Inc. carries a market capitalization of 2,018.35, placing it among publicly traded companies globally. Its enterprise value stands at 222,145.35, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of December 31, 2025, Genoil Inc. has 2.02B shares outstanding.

As of December 31, 2025, Genoil Inc. maintains a current ratio of 0.02, meaning it holds 0.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -43.26, indicating conservative leverage, while an interest coverage ratio of -15.89 demonstrates limited ability to service its debt obligations.

These figures cover the twelve months ended December 31, 2025. Return on assets (ROA) is negative at -924.06, reflecting losses generated across the asset base. The company generates approximately - - in revenue per employee across its workforce of 48.00, a quick read on workforce productivity versus industry peers.

As of the close on October 22, 2026, Genoil Inc.'s stock has gained approximately 68.92% over the past 52 weeks. The 50-day moving average sits at 0.01, while the 200-day moving average is 0.01.

Over the twelve months ended December 31, 2025, Genoil Inc. generated - - in revenue and converted that into -640,501.00 in net income, yielding earnings per share of 0.00. EBITDA reached -626,092.00, while operating income came in at -626,092.00.

As of December 31, 2025, Genoil Inc. holds 12.00 in cash and equivalents against 220,139.00 in total debt, resulting in a net debt position of 220,127.00. Total book value stands at -508,876.00, with working capital of -288,738.00 providing operational flexibility.

Genoil Inc. produced -516,297.00 in operating cash flow over the twelve months ended December 31, 2025.

These figures cover the twelve months ended December 31, 2025. Free cash flow yield is negative at -25,891.98: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -24,984.45, meaning Genoil Inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

As of December 31, 2025, Genoil Inc. has an Altman Z-Score of -30,247.62, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.